MARLBORO

ReWalk Takes Another Step Toward Medicare Coverage

Retrieved on: 
星期三, 九月 28, 2022
Risk, Health, Time, Macs, Medicare, SCI, CMS, Company, Form 10-K, Stroke, Patient, Mental health, Phrase, CEO, Quality of life, Uncertainty, GLOBE, SEC, Annual report, Robotics, Health insurance, ReWalk

ReWalk Robotics is actively engaged with CMS in its commitment to evaluate complex advanced technologies like exoskeletons.

Key Points: 
  • ReWalk Robotics is actively engaged with CMS in its commitment to evaluate complex advanced technologies like exoskeletons.
  • In light of this announcement, ReWalk will begin submitting cases for Medicare beneficiaries with spinal cord injury (SCI) to the MACs.
  • This is the latest step in ReWalks efforts to expand access to the Companys exoskeletons for Medicare beneficiaries with SCI.
  • For more information on the ReWalk systems, please visit rewalk.com
    ReWalk and ReStore are registered trademarks of ReWalk Robotics Ltd. in the United States and other jurisdictions.

German Federal Social Court Schedules Hearing on Classification of Exoskeleton Medical Devices for Spinal Cord Injured Individuals

Retrieved on: 
星期一, 九月 12, 2022
Paraplegia, Risk, Adoption, Time, Spinal cord, Spinal cord injury, Form 10-K, Review, Hearing, Stroke, U.S. Securities and Exchange Commission, Patient, Phrase, CEO, United Kingdom, Quality of life, Uncertainty, Nasdaq, Private Securities Litigation Reform Act, Insurance, Security (finance), GLOBE, SEC, Annual report, Classification, SHI, Robotics, Medical device, Health insurance, ReWalk

The courts decision will establish a new national policy for exoskeleton medical aids and will apply nationally to all Germans covered by Statutory Health Insurance (SHI).

Key Points: 
  • The courts decision will establish a new national policy for exoskeleton medical aids and will apply nationally to all Germans covered by Statutory Health Insurance (SHI).
  • Establishing a legal classification for exoskeletons will provide guidance for both patients and insurance companies, setting a reliable legal basis for the application process for the provision of exoskeletons.
  • The German healthcare system has led the way in its adoption of exoskeletons for spinal cord injured individuals.
  • ReWalk Robotics Ltd.develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

ReWalk Robotics Appoints Michael Lawless as Chief Financial Officer

Retrieved on: 
星期四, 九月 8, 2022
Phrase, Finance, Technology, Business administration, Form 10-K, Dartmouth College, Awareness, Master of Business Administration, Forecasting, Time, Tuck School of Business, Head, Risk, Board, CMS, Molecular imaging, Indian stock exchange, SEC, Brooks Automation, PerkinElmer, CFO, Swarthmore College, Financial compensation, GLOBE, Company, Robotics, Automation, LLC, Public policy, Uncertainty, Business, Annual report, Analysis, CPA, Growth, Acquisition, Employment, Economics, ReWalk

MARLBOROUGH, Mass.andBERLINand YOKNEAM ILIT,Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.(Nasdaq: RWLK) (the Company or ReWalk), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the appointment of Michael Lawless, CPA, as Chief Financial Officer, effective September 19, 2022.

Key Points: 
  • MARLBOROUGH, Mass.andBERLINand YOKNEAM ILIT,Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.(Nasdaq: RWLK) (the Company or ReWalk), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the appointment of Michael Lawless, CPA, as Chief Financial Officer, effective September 19, 2022.
  • Mike brings an extensive background in strategic finance and investor relations for leading life science businesses and will add significant value at ReWalk as we approach key milestones and anticipated upcoming growth, said Larry Jasinski, Chief Executive Officer.
  • I am very pleased to join ReWalk at this important and positive inflection point in the growth of the business, said Mr. Lawless.
  • Mr. Lawless most recently served as a CFO consultant for Danforth Advisors, LLC, where he provided financial and analytical support services to early-stage life science companies.

Loeb Leadership Celebrates the One-Year Anniversary of the Coach's Counsel Column in the Practising Law Institute (PLI) Chronicle

Retrieved on: 
星期四, 八月 18, 2022
Woman, Coach, Counsel, CEO, Leadership, Communication, ACC, Strategic partnership, Emotional intelligence, Practising Law Institute, PLI, Solution, Consultant, Management

NEW YORK, Aug. 18, 2022 /PRNewswire/ -- Loeb Leadership is celebrating the one-year anniversary of the Coach's Counsel Column, a monthly column in the Practising Law Institute (PLI) Chronicle: Insights and Perspectives for the Legal Community.

Key Points: 
  • NEW YORK, Aug. 18, 2022 /PRNewswire/ -- Loeb Leadership is celebrating the one-year anniversary of the Coach's Counsel Column, a monthly column in the Practising Law Institute (PLI) Chronicle: Insights and Perspectives for the Legal Community.
  • Each month, questions are submitted anonymously by PLI PLUS readers and answered by two of Loeb Leadership's executive leadership coaches, Natalie Loeb, MS, Founder and CEO of Loeb Leadership, and David B. Sarnoff, Esq., ACC, Director of Strategic Partnerships at Loeb Leadership.
  • Both Loeb and Sarnoff began their early careers in the legal industry and have since dedicated many years to encouraging diversity, equity, inclusion, and exemplary leadership within the community.
  • Loeb Leadership is based in Marlboro, NJ, and with over eighty coaches, facilitators, and consultants, offers services and training all over the world.

ReWalk Robotics Reports Second Quarter 2022 Financial Results

Retrieved on: 
星期二, 八月 9, 2022
FDA, Risk, United Kingdom, Industry, Phrase, Growth, SEC, Nasdaq, Compliance, Net, Income, Marketing, Quality of life, Stroke, Review, COVID-19, Company, Mission statement, Depreciation, CMS, GAAP, Uncertainty, Form 10-K, Robotics, Private Securities Litigation Reform Act, Time, Annual report, Bank, ReWalk

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 09, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and six months ended June 30, 2022.

Key Points: 
  • ReWalk is a registered trademark of ReWalk Robotics Ltd. in Israel and the United States.
  • ReStore is a registered trademark of ReWalk Robotics Ltd. in the United States, Europe and the United Kingdom.
  • In addition, there are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies and exclude expenses that may have a material impact on the Companys reported financial results.
  • ReWalk urges investors to review the reconciliation of the Companys non-GAAP financial measures to the comparable GAAP financial measures included below, and not to rely on any single financial measure to evaluate the Companys business.

Pye-Barker Fire & Safety Adds Complete Security Systems in New Jersey to its Family of Companies

Retrieved on: 
星期四, 八月 4, 2022
YMCA, Industry, CEO, Park, Family, Licensure, Security alarm, CSS, Partnership, CCTV, Culture, Completeness, Solution, ESA, Management, Risk management

ATLANTA, Aug. 4, 2022 /PRNewswire/ -- Pye-Barker Fire & Safety adds one of the largest full-service security providers in New Jersey, Complete Security Systems, Inc., to its alarm division and family of companies.

Key Points: 
  • ATLANTA, Aug. 4, 2022 /PRNewswire/ -- Pye-Barker Fire & Safety adds one of the largest full-service security providers in New Jersey, Complete Security Systems, Inc., to its alarm division and family of companies.
  • Complete Security Systems (CSS), headquartered in Marlboro, New Jersey, specializes in customized security solutions including intrusion alarms, fire alarms, CCTV and access control for commercial and residential customers.
  • Complete Security Systems is the only security company to receive the prestigious New Jersey Electronic Life Safety Association (NJELSA) Dealer Award for three years.
  • "I'm thrilled to be able to forge this partnership with Pye-Barker," said Chris Mosley, Complete Security Systems President.

ReWalk Robotics to Report Second Quarter 2022 Financial Results on August 9, 2022

Retrieved on: 
星期三, 八月 3, 2022
Stroke, ReWalk, Robotics, Quality of life, Trapping, Computer data storage

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Key Points: 
  • ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalks mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
  • Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.
  • ReWalk is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States.

ReWalk Robotics Announces Results of 2022 Annual Meeting

Retrieved on: 
星期二, 八月 2, 2022
Time, Annual Meetings of the International Monetary Fund and the World Bank Group, GLOBE, Nasdaq, U.S. Securities and Exchange Commission, LLM, SEC, Annual general meeting, Risk, Compliance, Private Securities Litigation Reform Act, Journal of Accounting and Economics, CMS, Uncertainty, Phrase, Board, Marketing, Deloitte, COVID-19, Form 10-K, CVC, Quality of life, Brainsway, Director, FDA, Company, Certified Public Accountant, Annual report, Stroke, Amdocs, Growth, GE Healthcare, Bar-Ilan University, Economics, Management, Risk management, ReWalk, Accounting

and BERLIN and YOKNEAM ILIT, Israel, Aug. 02, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (ReWalk or the Company), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the results of the Company's 2022 Annual Meeting of Shareholders (the Annual Meeting) based on the final tabulation of votes certified by an independent Inspector of Elections.

Key Points: 
  • and BERLIN and YOKNEAM ILIT, Israel, Aug. 02, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (ReWalk or the Company), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the results of the Company's 2022 Annual Meeting of Shareholders (the Annual Meeting) based on the final tabulation of votes certified by an independent Inspector of Elections.
  • At the Annual Meeting, shareholders voted to reelect Chief Executive Officer Larry Jasinski, Dr. John William Poduska and Randel Richner to the Board of Directors (the Board).
  • The final results of the Annual Meeting and all relevant information will be reported on a Form 8-K that will be filed with the U.S. Securities and Exchange Commission.
  • ReWalk and ReStore are registered trademarks of ReWalk Robotics Ltd. in the United States and other jurisdictions.

ReWalk Receives Court Approval for Share Repurchase Program

Retrieved on: 
星期四, 七月 21, 2022
Time, Annual Meetings of the International Monetary Fund and the World Bank Group, GLOBE, Nasdaq, SEC, Annual general meeting, Risk, ALL, Compliance, Private Securities Litigation Reform Act, CMS, Uncertainty, Phrase, Marketing, Board, COVID-19, Form 10-K, THE, Quality of life, CARD, FDA, Company, Method, Annual report, Stroke, Program, Growth, Security (finance), ReWalk

and BERLIN and YOKNEAM ILIT, Israel, July 21, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the Company or ReWalk), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that it has received Israeli court approval to repurchase up to $8 million of its Ordinary Shares, par valueNIS 0.25per share.

Key Points: 
  • and BERLIN and YOKNEAM ILIT, Israel, July 21, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the Company or ReWalk), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that it has received Israeli court approval to repurchase up to $8 million of its Ordinary Shares, par valueNIS 0.25per share.
  • Under the program, share repurchases may be made from time to time using a variety of methods, including open market transactions or in privately negotiated transactions.
  • The repurchase program does not require ReWalk to acquire a specific number of shares, and may be suspended or discontinued at any time.
  • For more information on the ReWalk systems, please visit rewalk.com
    ReWalk and ReStore are registered trademarks of ReWalk Robotics Ltd. in the United States and other jurisdictions.

FDA's decision to deny JUUL marketing authorization is a major public health victory; but swift action on other leading brands must be taken as new data shows youth e-cigarette initiation continues

Retrieved on: 
星期四, 六月 23, 2022
Public health, Depression, FDA, Anxiety, Truth, Culture, Tobacco, Multimedia, Blu, Social support, Smoking, Truth Initiative, Herbal cigarette, Risk, Smoker, Heart, Policy, Food, Smokeless tobacco, Research, JUUL, Menthol, Tobacco industry, Review, Vape shop, NJOY, Mental health, Logic, History, Social media, Social policy of the Joe Biden administration, Adult, News, Regulation of tobacco by the U.S. Food and Drug Administration, Program, Nicotine, Tobacco Master Settlement Agreement, Altria

WASHINGTON, June 23, 2022 /PRNewswire/ -- Today's announcement by the Food and Drug Administration to deny marketing authorizations for all JUUL e-cigarettes, thereby making them an illegally marketed product, is a huge public health victory that will save lives and protect millions of teens and young adults from the harms of nicotine use and risks of addiction. We applaud the Biden Administration and FDA for taking this urgently necessary and long-awaited action that clearly acknowledges the significant role JUUL played in igniting the ongoing youth e-cigarette epidemic, one that the U.S. Surgeon General says has had a negative impact on the physical and mental health of America's youth. By holding JUUL accountable and prioritizing public health over corporate profiteering, the FDA is making the right decision – one that we, with our public health partners, have been urgently calling for along with the removal of all flavored e-cigarettes, including menthol. 

Key Points: 
  • Surgeon General says has had a negative impact on the physical and mental health of America's youth.
  • The history of JUUL makes it clear that these products owned in part by Altria, the maker of Marlboro have no place in our society.
  • Just as young people deserve to live free of the harms of nicotine addiction, adult smokers deserve products that meet public health standards.
  • A completed FDA review can help determine if any tobacco-flavored e-cigarettes can help support adult smokers to improve their health outcomes.